Therapeutic Drug Monitoring of Cyclosporine A
KOMZÁKOVÁ I.1,3 ,ŠAFARČÍK K.2,3 ,BROZMANOVÁ H.1 ,GRUNDMANN M.1,3
1 Ústav klinické farmakologie FNsP a Zdravotně sociální fakulta Ostravské Univerzity,Ostrava 2 Klinika nukleární medicíny FNsP,Ostrava-Poruba 3 Farmakologický ústav lékařské fakulty Univerzity Palackého,Olomouc |
|
Summary:
Cyclosporine A (CyA)is a drug with a specific influence on the immune system and it is used both
to prevent tissue rejection of transplanted organs and to treat autoimmune diseases.The properties,
metabolism,and methods of therapeutic drug monitoring (TDM)in patients under immunosuppres-
sive therapy are described.TDM of CyA reflects the clinical condition of the patient during
immunosuppression and may include pharmacokinetic and pharmacodynamic data obtained either
from measuring CyA levels in blood,or from determining some other parameters,which are
modulated by CyA (II-2).Although TDM is mainly based on analyzing trough levels of CyA,the
determination of the whole biological exposition calculated as AUC enables better correlation with
the clinical state of patients.Pharmacodynamic parameters have not been measured routinely yet.
Key words:
cyclosporine A –CyA metabolites –TDM –trough level –AUC
|